EP PerMed 2025 Call: Advancing Pharmacogenomic Strategies for Personalized Medicine

The resources allocated for the new 2025 call of EP PerMed (European Partnership for Personalized Medicine), one of the partnerships funded by Horizon Europe in the life sciences field, amount to just over 36 million euros. This year's theme will be pharmacogenomic strategies for personalized medicine.

The European partnership launched in October 2023 continues its path, aiming to improve outcomes within sustainable healthcare systems through research, development, innovation, and implementation of personalized medicine approaches for the benefit of patients, citizens, and society.

To achieve this, EP PerMed operates through periodic calls to fund research projects carried out by multidisciplinary teams composed of members from multiple countries, the second of which was published yesterday, December 16.

What is the EP PerMed Partnership on Personalized Medicine?

The European Partners